Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
Linda D. Simmler, Matthias E. Liechti
Handbook of experimental pharmacology (2018), pp. 143-164
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency
Cihan Atila, Julie Refardt, Mirjam Christ‐Crain
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 8, pp. 487-500
Closed Access | Times Cited: 11
Drug-induced social connection: both MDMA and methamphetamine increase feelings of connectedness during controlled dyadic conversations
Hanna Molla, Royce Lee, Sonja Lyubomirsky, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters
Amy J. Eshleman, Shanthi Nagarajan, Katherine M. Wolfrum, et al.
Psychopharmacology (2018) Vol. 236, Iss. 3, pp. 939-952
Open Access | Times Cited: 55
Modulation of Social Cognition via Hallucinogens and “Entactogens”
Katrin H. Preller, Franz X. Vollenweider
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 52
Psychedelics in the treatment of unipolar and bipolar depression
Oliver G. Bosch, Simon Halm, Erich Seifritz
International Journal of Bipolar Disorders (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Subjective long-term emotional and social effects of recreational MDMA use: the role of setting and intentions
Timon Elmer, Tanya K. Vannoy, Erich Studerus, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Alpha-methyltryptamine and 5-(2-methylaminopropyl)-benzofuran (5-MAPB) fatal co-intoxication: case report and review of literature
Marie Epain, Nathalie Cartiser, Fabien Bévalot, et al.
International Journal of Legal Medicine (2024) Vol. 138, Iss. 5, pp. 1813-1820
Closed Access | Times Cited: 4
Solriamfetol enhances alertness and cognitive performance in mice
Meriem Haddar, Stamatina Tzanoulinou, Li‐Yuan Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
Hans Emanuel Oeri
Journal of Psychopharmacology (2020) Vol. 35, Iss. 5, pp. 512-536
Open Access | Times Cited: 32
Amphetamine-type stimulants: Novel insights into their actions and use patterns
Miguel I. Paz-Ramos, Silvia L. Cruz, Valeria Violante‐Soria
Revista de investigaci�n Cl�nica (2023) Vol. 75, Iss. 3
Open Access | Times Cited: 9
Human behavioral pharmacology of stimulant drugs: An update and narrative review
Ashley M. Strzelecki, Jessica Weafer, William W. Stoops
Advances in pharmacology (2022), pp. 77-103
Closed Access | Times Cited: 11
Trauma Under Psychedelics: MDMA Shows Protective Effects During the Peritraumatic Period
Ophir Netzer, Noa Magal, Yonatan Stern, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
The SLC6A3 gene polymorphism is related to the development of attentional functions but not to ADHD
Katarzyna Kuć, Maksymilian Bielecki, Ewa Racicka, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Characterization of neurotransmitter inhibition for seven cathinones by a proprietary fluorescent dye method
Mattias Persson, Svante Vikingsson, Robert Kronstrand, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 4, pp. 339-347
Open Access | Times Cited: 6
Dopaminergic neurotoxic effects of 3-TFMPP derivatives
Mohammed Majrashi, Mohammed Almaghrabi, Maali Fadan, et al.
Life Sciences (2018) Vol. 209, pp. 357-369
Closed Access | Times Cited: 17
MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence
Kainat Riaz, Sejal Suneel, Mohammad Hamza Bin Abdul Malik, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 159-159
Open Access | Times Cited: 5
Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences
Augusta Pisanu, Giacomo Lo Russo, Giuseppe Talani, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2336-2336
Open Access | Times Cited: 8
Pharmacotherapy of anxiety disorders in the 21st century: A call for novel approaches
Éric Bui, Franklin King, Andrew Melaragno
General Psychiatry (2019) Vol. 32, Iss. 6, pp. e100136-e100136
Open Access | Times Cited: 13
Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine
Candace B Johnson, Donna Walther, Matthew J. Baggott, et al.
Journal of Pharmacology and Experimental Therapeutics (2024), pp. JPET-001837
Open Access | Times Cited: 1
5-HT_FAsTR: a versatile, label-free, high-throughput, fluorescence-based microplate assay to quantify serotonin transport and release
Lina Bukowski, M. Ström, Jens Lindengren Andersen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study
Romain Icick, Ingrid Melle, Bruno Étain, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 6
Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field
Franklin King, Rebecca Hammond
FOCUS The Journal of Lifelong Learning in Psychiatry (2021) Vol. 19, Iss. 2, pp. 190-196
Open Access | Times Cited: 8
Jump-starting the conversation about harm reduction: making sense of drug effects
Mark Adley, Guy Jones, Fiona Measham
Drugs Education Prevention and Policy (2022) Vol. 30, Iss. 4, pp. 347-360
Open Access | Times Cited: 6
Introduction to the chemistry and pharmacology of psychedelic drugs
Scott R. Walker, Glenn A. Pullella, Matthew Piggott, et al.
Australian Journal of Chemistry (2023) Vol. 76, Iss. 5, pp. 236-257
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top